Pacific Capital Wealth Advisors’s Boston Scientific BSX Stock Holding History

Pacific Capital Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-327	Closed	-$29.2K	–	124
2024 Q4	$29.2K	Sell	327 -24	-7%	-$2.11K	﹤0.01%	189
2024 Q3	$29.4K	Buy	351 +24	+7%	+$1.89K	﹤0.01%	197
2024 Q2	$25.2K	Buy	327 +231	+241%	+$16.9K	﹤0.01%	208
2024 Q1	$6.58K	Buy	+96	New	+$6.17K	﹤0.01%	269

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Pacific Capital Wealth Advisors's BSX Position: Q1 2025 in Review

Pacific Capital Wealth Advisors sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 327 shares — an estimated $29.2K sold.

Pacific Capital Wealth Advisors first reported a position in BSX in Q1 2024 and held it in 4 quarters. The position peaked at $29.4K in Q3 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

Pacific Capital Wealth Advisors reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
Pacific Capital Wealth Advisors sold 327 Boston Scientific shares in Q1 2025, an estimated $29.2K.
Pacific Capital Wealth Advisors first reported a position in Boston Scientific in Q1 2024 and held it in 4 quarters.
Pacific Capital Wealth Advisors's Boston Scientific position peaked at $29.4K in Q3 2024.
1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Pacific Capital Wealth Advisors's 13F filing for Q1 2025, filed 18 Apr 2025.